1-ALPHA,20,23-TRIHYDROXY-VITAMIN-D3;[1,20,23(OH)3D3]
Compound with spectra: 1 NMR
![1-ALPHA,20,23-TRIHYDROXY-VITAMIN-D3;[1,20,23(OH)3D3]](/api/compound/4snPtBQmrpr.png?ph=true&h=300&w=458 "1-ALPHA,20,23-TRIHYDROXY-VITAMIN-D3;[1,20,23(OH)3D3]")
| SpectraBase Compound ID | 4snPtBQmrpr |
|---|---|
| InChI | InChI=1S/C27H44O4/c1-17(2)13-22(29)16-27(5,31)25-11-10-23-19(7-6-12-26(23,25)4)8-9-20-14-21(28)15-24(30)18(20)3/h8-9,17,21-25,28-31H,3,6-7,10-16H2,1-2,4-5H3/b19-8+,20-9-/t21-,22?,23-,24-,25-,26-,27-/m0/s1 |
| InChIKey | ZMDIGTZBNFTKRP-GOTLPRRFSA-N |
| Mol Weight | 432.6 g/mol |
| Molecular Formula | C27H44O4 |
| Exact Mass | 432.32396 g/mol |
| Enantiomer InChIKey | ZMDIGTZBNFTKRP-HNVADHEISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
25-Dehydro-1.alpha.-hydroxy-24-propyl-Vitamin D3-26,23-lactone
(23S,25R)-1.alpha.,25-Dihydroxyvitamin D3 26,23-Lactone
8-E-BROMOMETHYLENE-(20-S,23-S)-EPOXYMETHANO-25-HYDROXYDES-A,B-CHOLESTA-8-ONE
(1R,3S,5Z)-5-[(E)-2-((1R,3aS,7aR)-Hexahydro-1-{(S)-1-[5-(2-hydroxypropan-2-yl)-1H-tetrazol-1-yl]propan-2-yl}-7a-methyl-1H-inden-4(7aH)-ylidene)ethylidene]-4-methylenecyclohexane-1,3-diol
25-Dehydro-1.alpha.-hydroxy-24-methyl-Vitamin D3-26,23-lactone
(2S)-2-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylene-cyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]propan-1-ol
1,5-BIS-(TRI-ISOPROPYLSILYL)-1-ALPHA-HYDROXYVITAMIN-D(3)
(1R,3R,Z)-5-(2-((7aR,E)-1-((2R)-4,6-dihydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylene-2-propoxycyclohexane-1,3-diol
Tristrimethylsilyl ether derivative of 1,25-dihydroxyvitamin D2
18-NORPIMARA-8(14),15-DIEN-4-OL
| Title | Journal or Book | Year |
|---|---|---|
| Purified Mouse CYP27B1 Can Hydroxylate 20,23-Dihydroxyvitamin D3, Producing 1α,20,23-Trihydroxyvitamin D3, Which Has Altered Biological Activity | Drug Metabolism and Disposition | 2010 |